Abstract
The functional roles of memory B and T lymphocytes underlie the phenomenal success of prophylactic vaccinations, which have decreased morbidities and mortalities from infectious diseases globally over the last 50 years. However, it is becoming increasingly appreciated that memory cells are also capable of mediating the pathology associated with autoimmune disorders and transplant rejection, and may pose a significant barrier to future clinical advancement in immunoregulation. Therefore, understanding the unique properties of memory lymphocytes (as compared to their naive precursors) is a major area of investigation. Here, we focus on one of those singular properties of memory T cells (TM)—rapid recall. As will be discussed in more detail, rapid recall refers to the ability of quiescent TM cells to efficiently and robustly express 'effector functions' following stimulation. Studies that have advanced our understanding of TM cells' rapid recall using CD4+ T cells have been expertly reviewed elsewhere 1, so we will focus primarily on studies of CD8+ T cells. We will first review the different ways that CD8+ TM cells can be generated, followed by discussing how this influences their functional properties in the settings of immune protection and pathology. Then, rapid recall ability will be discussed, with emphasis placed on what is currently known about the mechanisms that underlie this unique property of TM cells.
Similar content being viewed by others
The generation of CD8+ TM cells
Memory T cells are derived from naÑ—ve precursors (TN cells); however, research over the past 20 years has revealed a surprising number of contexts in which this can occur 2, 3, 4. They all involve a signal received through the T-cell receptor (TCR), via its interactions with foreign or self antigens (Ag) and can take place in an inflammatory setting (such as infection) or in the presence of elevated levels of pro-survival and proliferation cytokines during lymphopenia.
Acute pathogenic infections
The process of CD8+ TM-cell differentiation in the context of acute pathogenic infection has been characterized in the most detail 5, 6. Rare TN cells, specific for pathogen-derived peptides, encounter Ag-presenting cells (APC) in lymph nodes draining infected tissues, where TN cells receive a combination of signals from the TCR, co-stimulatory molecules and cytokine receptors 5, 7. In this context, TN-cell activation results in massive proliferation (clonal expansion phase), where the number of CD8+ T cells specific for a given viral peptide can increase by as much as 50 000-fold over 7-8 days 8, 9, 10, 11. During this time, differentiation to effector T cells (TE) occurs, with CD8+ T cells developing the ability to migrate to peripheral tissues, abundantly secrete pro-inflammatory cytokines (such as TNFα and IFNγ) and lyse infected target cells 6. Following pathogen clearance, 90-95% of the TE cells die (contraction phase), leaving behind a population of pathogen-specific CD8+ TM cells that is maintained at a remarkably stable level for the lifetime of the host 11.
Following an acute infection, the generation of a CD8+ TM-cell population effectively increases the number of pathogen-specific CD8+ T cells, giving the TM-cell population a numerical advantage over their TN-cell counterparts in controlling subsequent challenges by the same pathogen. Thus, this quantitative increase in precursor frequency is one of the distinguishing features of immunological memory 12, 13; and long-term maintenance of CD8+ TM-cell populations is achieved via slow, Ag-independent turnover of individual TM cells 14, 15, 16, 17. However, this 'homeostatic proliferation' is not the only property that distinguishes TM cells from their TN-cell precursors. Specifically, there are subsets of TM cells that can migrate to peripheral tissues, enhancing surveillance of pathogen entry sites 18, 19, 20, 21. Furthermore, after stimulation, CD8+ TM cells may more rapidly enter and progress through the cell cycle than TN cells 22, 23, 24. Lastly, another distinctive feature of CD8+ TM cells is their ability to robustly produce cytokines and kill infected target cells within hours following stimulation. This contrasts with their TN-cell precursors, which require replication and differentiation over several days to achieve the same functional capacity 22, 25, 26. Together, heightened precursor frequency, expanded anatomical distribution, enhanced proliferative capacity and rapid recall ability comprise the hallmark attributes of protective CD8+ TM cells.
Lymphopenia-induced proliferation
In addition to infection-induced proliferation, CD8+ TN cells are also stimulated to divide under conditions of lymphopenia, such as that found in neonates or after lymphoablative therapies for cancers. Surprisingly, this does not result in 'homeostatic proliferation,' which would renew the TN-cell population. Rather, under lymphopenic conditions, CD8+ TN cells can proliferate and differentiate into cells that possess the phenotypic and functional properties, as well as a gene expression profile, similar to that of TM cells generated after pathogenic infections 4, 27, 28. This phenomenon is termed 'lymphopenia-induced proliferation' (LIP) and it has several implications for our understanding of the contribution of CD8+ TM cells to immune protection and pathology.
Since the first demonstrations that LIP can change the surface marker profile of CD8+ TN cells into one that resembles that of TM cells, several properties of these cells have been defined 4. Importantly, like TM cells formed after acute pathogenic infections, several groups have shown that CD8+ TM cells generated via LIP have cytotoxic ability, can efficiently upregulate production of effector cytokines and chemokines following stimulation and are capable of robust proliferation after Ag challenge in vivo 25, 29, 30. Moreover, these cells are dependent on the presence of helper CD4+ T cells (CD4+ TH) for normal differentiation, a requirement shared with CD8+ TM cells generated by acute infections 25, 31, 32. It should be noted that CD8+ TN cells undergoing LIP do not appear to pass through a classical 'effector' stage of differentiation, characterized by the upregulation of the activation markers CD69 and CD25, nor do they downregulate the adhesion molecule CD62L, a process which facilitates homing to tissues by excluding these cells from lymph nodes 4, 28, 30, 33. In fact, an important distinction between TM cells generated via LIP and those generated by infection may be the ability of the latter to migrate to peripheral tissues. It is now well-known that TM cells generated after acute infections are heterogeneous, even among a population with the same TCR specificity 19, 20. Effector memory (TEM) cells are characterized by low levels of the homing molecules CD62L and CCR7, excluding them from lymph nodes and facilitating their migration to peripheral tissues. Conversely, central memory (TCM) cells express high levels of CD62L and CCR7, facilitating their accumulation in lymph nodes 34. Whether this heterogeneity also exists within TM cells generated via LIP is not yet clear. Nonetheless, the functional properties of CD8+ TM cells generated via LIP can bear a striking resemblance to those of TM cells formed after acute pathogenic infections 4.
In summary, CD8+ TM cells generated after acute infections by intracellular pathogens have been called 'true' memory cells 25 and their importance to the efficacy of natural anamnestic responses, as well as those amplified by vaccination, is clear. However, over the past decade, it has been convincingly demonstrated that CD8+ TM cells can be derived from TN cells that undergo proliferation and differentiation in a lymphopenic environment. Given that both types of CD8+ TM cells have the capacity to exert the effector functions that mediate protection and pathology, each will be discussed in these two contexts in the next section, with emphasis being placed on the distinctive rapid recall ability of CD8+ TM cells.
CD8+ TM cells' rapid recall in infection and disease
Together, the unique attributes of CD8+ TM cells – found in their frequencies, migration patterns, longevity and functional capacity – have led to a summation of CD8+ TM cells as both 'quantitatively and qualitatively' superior to their TN precursors. Given the quantitative differences with TN-cell populations, support for the importance of TM cell qualitative enhancements has come largely from studies where equal numbers of TN and TM cells, specific for the same epitope, have been compared. Technically, this has been difficult to achieve, because of the very small number of CD8+ TN cells possessing the same TCR specificity in adult mice (estimated to be ∼80-1 200 for any specific MHC I-restricted epitope 24, 35). However, such experiments have been done with TCR transgenic (Tg) CD8+ T cells, which are engineered to express TCRs that recognize epitopes from model Ags, such as ovalbumin, or model pathogens, such as lymphocytic choriomeningitis virus (LCMV) 36. The absence of cognate Ag expression in TCR Tg mice results in a mostly naїve, monoclonal CD8+ T-cell population (particularly when re-arrangement of non-Tg TCRs is suppressed by additional crossing onto RAG-deficient backgrounds). Adoptive transfer of Tg CD8+ TN cells to naїve host mice, followed by stimulation of the donor cells with cognate Ag, can generate a TCR Tg CD8+ TM-cell population. These TM and TN cells can then be purified and their properties compared on a 'per cell basis,' either in vivo or in vitro.
When equal numbers of CD8+ TCR Tg TN and TM cells are adoptively transferred to separate naïve hosts, the TM cells mediate superior protection following infectious challenge and they are uniquely able to clear chronic viral infections 37, 38, 39. These TM cells can be generated by adoptive transfer of CD8+ TCR Tg TN cells to naïve hosts, followed by infection with pathogens expressing the cognate epitope recognized by the Tg TCR. In addition, Jameson and colleagues demonstrated the ability of TCR Tg CD8+ TM cells generated via LIP to control pathogen replication more efficiently than their TN precursors, indicating that pathogenic infection is not required to generate a population of highly functional, protective CD8+ TM cells 25, 40.
The enhanced protective capacity of TM cells initially demonstrated in infection models predicted that CD8+ TM cells may be especially damaging in settings of transplant rejection and autoimmunity. Indeed, it was recently reported that CD8+ TM cells are superior to their TN counterparts in their ability to reject an allograft. Wood and colleagues 41 utilized TCR Tg BM3 CD8+ T cells, with a TCR specific for the MHC Class I allo-Ag H-2Kb. Naїve BM3 cells were adoptively transferred to RAG−/− hosts, which were then given an H-2Kb skin allograft, resulting in activation and conversion of the BM3 donor cells to a memory phenotype. The ability of BM3 TN or TM cells to reject an allograft was then compared by transfer of an equal number of TN or TM cells to RAG−/− hosts, which also received an H-2Kb skin allograft. The TM cells mediated graft rejection more rapidly than their TN counterparts (17 days versus 27 days mean graft survival time). This correlated with the ability of the TM cells to efficiently produce IFNγ after stimulation with allo-Ag in vitro 41. Notably, the absence of other lymphocytes in the RAG−/− recipients demonstrated the sufficiency of CD8+ T cells for graft rejection, as RAG−/− recipients that did not receive CD8+ T cells were 100% tolerant.
The enhanced pathological potential of CD8+ TM has also been observed in a mouse model of Type 1 diabetes. Hernandez and colleagues 42 utilized TCR Tg CD8+ T cells specific for a peptide from influenza virus. These cells were transferred into mice that expressed the viral peptide as a neo-self Ag exclusively in pancreatic beta cells, and that had also been rendered lymphopenic via irradiation. The TCR Tg cells underwent LIP, acquired a memory phenotype and were able to produce cytokines efficiently after stimulation with the specific peptide. Moreover, 100% of the recipient mice developed diabetes, while the same mice that had not been irradiated (and where differentiation of CD8+ TN to TM cells did not occur) were healthy.
Here, a distinction can be made between the unique properties of 'resting' TM cells (manifested prior to secondary infections and stimulations) and those of stimulated TM cells (Figure 1). Specifically, in the absence of stimulation, TM cells are distinct from TN cells in their ability to migrate to peripheral, non-lymphoid tissues 20, 34. Thus, while rapid recall likely contributed to the superior TM cell-mediated protection and pathology in the studies described above, these adoptive transfer experiments cannot exclude the possibility that TM cells only appeared to respond more quickly because they encountered Ag in peripheral tissues before their TN counterparts. However, many experiments have demonstrated the enhanced functional capacity of TM cells stimulated in vitro, where migration is not an issue and where the conditions of stimulation were more stringently controlled (such as APC number and peptide density). Following in vitro stimulation, TM cells display enhanced proliferation and more efficient cytokine production than their TN precursors (discussed below). Therefore, for the remainder of this review, we will refer to these stimulation-induced properties as the enhanced 'functional capacity' of CD8+ TM cells that form the essence of their rapid recall ability.
Phenotypes associated with CD8+ TM cells' rapid recall ability
Proliferation
A hallmark feature of both CD8+ TN and TM cells is their ability for exponential proliferation following stimulation. However, whether TM cells have an enhanced proliferative capacity (for example, begin dividing sooner after stimulation and/or display more rapid accumulation of progeny cells), is still controversial. Initially, Rocha and colleagues 22 reported that, following stimulation, CD8+ TM cells enter the cell cycle earlier than TN cells and progress through it more rapidly. Using TCR Tg CD8+ TN or TM cells (specific for a male HY Ag) adoptively transferred into separate female hosts immunized with male cells, they found that all TM cells detected at 24 h after transfer had increased in size, indicative of the growth phase prior to cell division; whereas very few TN cells were blasting at the same time point. Furthermore, mathematical modeling of their CFSE dilution profiles revealed that TM cells had a shorter lag time to their first division (by 15 h) and progressed slightly faster through subsequent cell cycles than their TN-cell counterparts 22. These results have been criticized due to some particular properties of HY-specific TCR Tg cells that may not be representative of naturally occurring polyclonal CD8+ TN cells, including the fact that they do not undergo LIP 22, 28. In addition, since the HY-specific TM cells were generated in a non-infectious context, they may have been deprived of the abundant amounts of pro-inflammatory cytokines known to regulate TM-cell differentiation during pathogenic infections 5, 43, 44. Thus, their properties may not accurately represent pathogen-specific CD8+ TM cells. However, Ahmed and colleagues performed similar experiments using the LCMV infection model. They transferred equal numbers of LCMV-specific TCR Tg CD8+ TN and TM cells into the same host, which was then acutely infected with LCMV. They found greater accumulation of progeny cells derived from the TM-cell population at multiple time points post-infection 45. Thus, these results using an infection model are consistent with the initial findings described above.
Differences in proliferative ability between CD8+ TN and TM cells have recently been called into question by Carbone and colleagues. They compared TCR Tg CD8+ TN and TM cells specific for a peptide from a glycoprotein of herpes simplex virus (HSV). To generate TM cells, Tg TN cells were adoptively transferred into naÑ—ve host mice, followed by infection of hosts with HSV 46. The CFSE dilution profiles of these TM and TN cells were compared following stimulation with HSV peptide in vitro over several days. Cells in neither population had divided after 24 h, while the same percentage of TN and TM cells had divided at later time points and appeared to have undergone approximately the same number of divisions 46. When these TN and TM cells were adoptively transferred into separate recipients challenged with HSV, the progeny of the TN and TM cells accumulated at the same rate in the spleen and trafficked equally well to the site of infection. Thus, at least in this model of localized HSV infection, there appeared to be no difference between CD8+ TN and TM cells in their ability to proliferate in response to stimulation in vitro or accumulate in response to infection in vivo.
In summary, work in murine models has shown that when the number of precursor cells is controlled for, CD8+ TM cells can accumulate at the same rate or faster than TN cells following stimulation, depending on the experimental system. These experiments have relied exclusively on the use of TCR Tg cells, whose characteristics may not represent endogenous TN and TM-cell populations 5. The recent advent of methodology that allows the purification of rare TN cells should allow comparisons of non-Tg, polyclonal CD8+ TN and TM cells. Using this method, Kedl and colleagues have compared naturally occurring CD8+ TN and TM cells specific for the same viral epitope, and reported that a higher frequency of TM than TN cells had proliferated after 3 days of in vitro stimulation 24. Lastly, CD8+ TM cells accumulated more rapidly in vivo than TN cells following infection with either LCMV or vaccinia virus 45, but not with HSV 46, suggesting that the enhanced proliferative capacity of TM cells may be particularly sensitive to the distinct inflammatory environments presented by different pathogens.
Cytokine production and cytotoxicity
Given the relatively rare frequency of pathogen-specific TM cells and the rapid replication that microbes are capable of, it may be expected that the effector functions of CD8+ TM cells would not be limited to target cell lysis and might include the production of chemokines that can recruit innate immune cells, like macrophages and neutrophils, and cytokines that can activate them. In fact, an important part of CD8+ TM cells' rapid recall ability is their efficient upregulation of cytokine and chemokine production following stimulation. This phenotype is well established in infection and immunization models, and so we will briefly review this work before highlighting some more recent demonstrations of TM cells' rapid recall in models of autoimmunity and transplantation.
As discussed, the use of monoclonal, TCR Tg cells has allowed comparisons of the properties of TN and TM cells on a per cell basis, controlling for potential differences in the number of cells in each population and in the affinity of TCRs that could be present in polyclonal populations specific for the same epitope. Furthermore, in vitro stimulation with specific peptide controls for potential differences in in vivo Ag accessibility. Using the HY TCR Tg system, Rocha and colleagues found that after 7 h of in vitro stimulation with peptide-pulsed splenocytes, ∼70% of CD8+ TM cells expressed two or more cytokine mRNAs (IFNγ, IL-2 and/or Perforin), while double cytokine-producing TN cells were not detected 22. Similarly, CD8+ TM cells generated by LIP were also capable of efficient recall of cytokine production, as TCR Tg OT-I TM cells (generated by transfer of OT-I TN cells into partially irradiated congenic hosts) produced IFNγ, IL-2 and TNFα more rapidly than naїve (OT-I) cells after in vitro stimulation with specific peptide 25.
Recent studies have correlated the enhanced functionality of TM cells with their potential pathological roles. Jones and colleagues used a model of alloreactivity with TCR Tg CD8+ T cells specific for the MHC Class I allo-Ag H-2Kb (BM3 cells). They adoptively transferred purified naïve (CD44lo) BM3 CD8+ T cells into congenic RAG−/− hosts, which received an allogeneic H-2Kb skin graft. The grafts were rejected in a manner that generated a long-lived population of BM3 TM cells 41. Also, following overnight incubation with allogeneic H-2Kb-expressing stimulator cells, the BM3 TM cells secreted more IFNγ than their TN-cell precursors, demonstrating the efficient recall ability of CD8+ TM cells in a transplantation model 41. Furthermore, cytokine production from TM cells may contribute to pathology in the autoimmune disease rheumatoid arthritis (RA). Recently, it was shown that RA patients contain a population of peripheral blood TEM CD4+ T cells (CD45RO+CD45RA−CCR7−) that produces IFNγ rapidly after stimulation with a set of cytokines present in inflamed joints, namely, IL-12, IL-15 and IL-18 47. Importantly, prior to stimulation, the same TM cells expressed high levels of these cytokine receptors, suggesting that chronic, cytokine-mediated activation of TM cells can in turn result in their production of additional pro-inflammatory cytokines, sustaining cycles of immune activation in autoimmune disease 47.
Lastly, the ability of stimulated CD8+ TM cells to rapidly lyse infected target cells was not initially appreciated based on in vitro assays 48, but more recent data indicate that TM cells can kill extremely rapidly and efficiently in vivo 26, 49. Using a novel in vivo cytotoxicity assay, Barber et al. showed that fluorescently-labeled target cells pulsed with LCMV-derived peptides were rapidly eliminated when transferred into LCMV-immune, but not naÑ—ve, mice. Specifically, 10-20% of peptide-pulsed target cells were eliminated by 1 h post-injection and 90% of target cells were eliminated within 4 h 26.
Remarkably, CD8+ TM cells are able to rapidly activate multiple effector cell functions within hours following stimulation, a feature that distinguishes them from their TN-cell precursors. Unfortunately, current studies of recall responses have focused on a few known effector molecules, but it is likely that many factors are rapidly induced in TM cells following stimulation that contribute to their enhanced functionality. This complicates a rigorous testing of the role that TM cells' rapid recall ability has in the outcomes of immune responses. The test is further hampered by a lack of basic knowledge about the specific signaling pathways and crucial regulators involved, thus precluding their functional inhibition. However, the distinct mechanisms used by TM cells to execute rapid recall responses are starting to be elucidated and will be the subject of the remainder of this review.
Mechanisms underlying CD8+ TM cells' rapid recall ability
Although the rapid recall ability of CD8+ TM cells is well-established, the mechanisms underlying this ability are only beginning to be discovered. It is important to consider that the proliferation, secretion of effector cytokines and manifestation of cytolytic ability by CD8+ T cells all require the transmission of signal(s) received via the TCR and associated co-stimulatory molecules and/or cytokine receptors. Thus, there are many levels at which CD8+ T-cell function can be regulated that could potentially differ between TN and TM cells. These include the 'relay' of TCR and cytokine receptor-mediated signals (via intracellular signaling cascades) and the 'execution' of the signals (via changes in protein activity and/or expression). A general theme that has been proposed to underlie rapid recall ability is that, even when at rest, TM cells exist in a 'ready-to-respond' state. There is now evidence to support this hypothesis at multiple levels of regulation.
TCR-proximal signaling events
Given the complex, polyclonal T-cell responses to pathogen-derived Ags, together with the exponential expansion and profound contraction of CD8+ T cells during infection, it was initially proposed that CD8+ T-cell clones with high affinity for foreign-peptide-MHC complexes were selectively expanded after infection and retained in the TM-cell pool, thus explaining the efficacy of TM-cell recall responses. However, in an elegant study designed to ask whether or not such 'affinity maturation' is necessary for the generation of a highly functional, pathogen-specific TM-cell pool, Slifka et al. 50 found that CD8+ TCR Tg cells, specific for an LCMV-derived peptide, developed the ability to respond to lower concentrations of peptide during the primary response to LCMV infection. Moreover, this heightened sensitivity (termed 'functional avidity maturation') was maintained at a population level long after the infection was cleared. The use of monoclonal, TCR Tg cells (on a RAG−/− background) eliminated the possibility that higher affinity TCR clones were selectively retained in the TM-cell pool, and so the authors postulated that TM cells' heightened responsiveness involved an enhanced capacity for TCR-mediated signal transduction. Though this hypothesis was not directly tested, they did show that, on average, individual virus-specific effector CD8+ T cells (at day 8 post-infection) contained a higher level of the TCR-associated tyrosine kinase Lck than their TN-cell precursors, and that this higher level was maintained in resting TM cells 50. These experiments first identified a positive correlation between levels of TCR-associated signaling components and CD8+ TM-cell cytokine production, a correlation that has been confirmed and extended by others 51. However, precisely how higher resting Lck levels contribute to CD8+ TM cells' enhanced functional capacity after stimulation remains to be determined.
Additional evidence suggested that signals received via the TCR may be relayed differently by CD8+ TN and TM cells, and possibly in a manner that is more efficient in TM cells. It does not appear that there are differences in the levels of surface TCR or associated CD3 complex components between TN and TM cells 51. However, Kersh et al. 51 found that, long after an acute viral infection had been cleared, virus-specific CD8+ TM cells contained elevated resting levels of phosphorylated LAT, which is the active form of a TCR-proximal scaffolding molecule. This phenotype positively correlated with TM cells' more efficient accumulation of phosphorylated signaling molecules downstream of LAT (such as ERK 1/2, p38 and JNK2), as compared to TN cells, 15 min after in vivo injection of specific peptide. Together, these results suggested that pre-assembly of the TCR signal transduction cascade may facilitate more rapid signaling in CD8+ TM cells.
Furthermore, using a Tg mouse model, where expression of the TCR proximal kinase Lck was controlled by a tetracycline-responsive promoter, Zamoyska and colleagues 52 found that CD8+ TM were fully able to produce effector cytokines in response to specific peptide stimulation without Lck, demonstrating that Lck is not required for TCR-mediated signaling in CD8+ TM cells. Importantly, Lck independence was found at a range of peptide concentrations, showing that the enhanced sensitivity of TM cells to stimulation is also independent of Lck 52. In contrast, CD8+ TN cells were completely dependent on Lck for their activation and differentiation. It should be noted that an Lck-related Src-family tyrosine kinase, Fyn, can partially substitute for Lck during T-cell development 53, and requirements for Fyn in CD8+ TM cell signaling remain to be tested.
In summary, although it appears that surface TCR levels are the same on TN and TM cells 50, 51, there are data to suggest that CD8+ TM cells may have proximal TCR-associated molecules in a 'response-ready' configuration prior to stimulation, and/or may short-circuit some of the pathways used by TN cells. Given the role of the TCR as the major signal initiator for T cells, especially in the context of pathogenic infection 11, 54, it is possible that rapid relay of TCR-mediated signaling events is sufficient to explain the enhanced functional capacity of TM cells. However, several lines of evidence now support the idea that the 'ready-to-respond' state of resting CD8+ TM cells also involves TCR-distal mechanisms, including distinct chromatin conformations and mRNA expression profiles from those of their TN precursors.
Chromatin remodeling
The evidence that proximal TCR signaling relays are not wholly responsible for the enhanced functional capacity of CD8+ TM cells was provided by Shen and colleagues 55, who investigated the mechanistic basis for the dysfunctional phenotype of CD8+ TM cells generated in the absence of CD4+ T cell help. Initially, studies by the Shen and Bevan groups showed that such 'unhelped' CD8+ TM cells were defective in their ability to control bacterial replication following secondary infections 31, 32. Northrop et al. showed that this was associated with decreased per cell production of IFNγ by unhelped TM cells, as compared to their helped counterparts. This was true for both polyclonal and monoclonal (TCR Tg) CD8+ TM cells, the latter indicating that selection for lower affinity clones could not explain the defect in the unhelped environment. Most importantly, this defect in IFNγ production was also observed when a chemical stimulation protocol was used that bypassed proximal TCR signaling events 55.
An alternative explanation for the inability of unhelped CD8+ TM cells to robustly upregulate IFNγ production was that the IFNγ locus was in a 'closed' conformation in these cells, and not easily accessible to the transcriptional machinery. To test this hypothesis, two chromatin modifications were analyzed in CD8+ T cells – DNA methylation at CpG dinucleotides (whose presence correlates with a closed chromatin conformation) and di-acetylation of histone H3 (whose presence is associated with an 'open' chromatin conformation). In CD4+ T-cell-sufficient wild-type mice, CpG sites within regulatory regions of Ifng were heavily methylated in TN cells. This methylation was dramatically lower in effector cells present at the peak of infection, and this hypomethylated state was maintained in resting TM cells. However, CpG methylation levels at Ifng were equivalent between helped and unhelped CD8+ TM cells. In contrast, levels of di-acetylated histone H3 (diAcH3) were dramatically lower in unhelped TM cells as compared to their helped counterparts. This led the authors to conclude that the failure of unhelped TM cells to rapidly upregulate IFNγ was due, at least in part, to their inability to acquire and/or maintain appropriate levels of histone acetylation at the IFNγ locus.
A pattern of CpG hypermethylation at the IFNγ locus in CD8+ TN cells and hypomethylation in TM cells was consistently observed in several reports, with studies in infection models confirming results originally obtained using naturally occurring polyclonal (CD44hi) CD8+ TM cells 56, 57. Specifically, a decade ago, Kelso and colleagues reported CpG hypomethylation within Ifng regulatory regions in CD44hi CD8+ TM cells. Conversely, polyclonal CD44lo CD8+ TN cells were hypermethylated at the same sites. Notably, they also demonstrated the heritability of these CpG patterns in the clonal progeny of TM cells that had been isolated and cultured at a single cell level 57, 58. Thus, multiple studies support the idea that the IFNγ locus attains a more open chromatin conformation during CD8+ T-cell differentiation that is maintained in the long-lived population of TM cells.
Importantly, the few studies that have compared human CD8+ TN and TM cells have found similar patterns of chromatin modifications to those reported in murine models. Weng and colleagues compared levels of acetylated histone H3 (K9) at effector cytokine and chemokine loci 59. They found that higher mRNA levels in stimulated TM than TN cells correlated with higher levels of H3K9Ac in the TM cells. Given the well-known association of H3K9Ac with active transcription 60, this result was not very surprising. Interestingly though, at some cytokine loci, the H3K9Ac level was also higher in TM than in TN cells analyzed immediately ex vivo, when differences in cytokine mRNA levels between the two cell types were not detected, suggesting that these loci were 'poised' for activation in TM cells. However, it should be noted that the authors did not provide compelling evidence for a strong correlation of resting histone acetylation levels with activation-induced transcript induction, as mRNA levels in activated cells were not measured until 72 h post-stimulation. Given the potential for up to 1 000-fold increases in cytokine mRNA levels within 4-8 h of TM cell stimulation 56, the idea that such histone modifications are indicative of loci that are poised for 'rapid' expression remains to be tested.
More recently, Weng and colleagues have focused on mapping histone methylation levels in human CD8+ TN and TM cells. Using chromatin immunoprecipitation combined with genome-wide DNA sequencing (ChIP-seq), they mapped the density of two histone H3 modifications: tri-methylation of lysine 4 (a mark associated with open chromatin) and tri-methylation of lysine 27 (a mark of closed chromatin) 61. Within this rich data set, two observations stand out. First, a positive correlation between the H3K4me3 abundance of a locus and its mRNA level, which has been observed for other cell types, was confirmed for CD8+ T cells on a genome-wide basis. Likewise, a negative correlation between the H3K27me3 abundance and mRNA expression level of a locus was also confirmed. Second, they found enriched H3K4me3 at many 'poised' loci in resting TM cells (loci whose expression is rapidly induced following TM-cell stimulation). This observation builds on their previous reports, which found abundant di-acetylation of histone H3 at poised loci in CD8+ TM cells 59, 62, and suggests that H3K4me3 and diAcH3 may act cooperatively in keeping this 'poised' subset of loci open and accessible to the transcriptional machinery in resting TM cells. In addition, among the actively transcribed genes in TM cells, they found some depleted of diAcH3, but enriched for H3K4me3, and others with the opposite pattern (depleted of H3K4me3 and enriched for diAcH3), providing the first evidence for a division of labor among different modifications in CD8+ TM cells. Given this solid foundation, future studies using the powerful ChIP-seq technique should map the localization and abundance of diAcH3 (and other marks of open chromatin) in CD8+ TM cells, and address the correlation of these marks with silent, actively transcribed and poised loci. Such studies should strengthen the correlations found thus far and build a more detailed model of histone modification patterns in resting TM cells, facilitating investigations into chromatin-based mechanisms underlying TM cells' rapid recall ability.
Together, these studies suggest that development of rapid recall ability by CD8+ TM cells is associated with the acquisition and maintenance of distinct chromatin modification patterns at effector cytokine and chemokine loci. This work also highlights the fact that, to date, histone modifications in CD8+ T cells have been mapped primarily at loci encoding effector molecules (Table 1), leaving open the question of whether loci encoding regulators of other processes, such as proliferation, migration, energy metabolism and/or biosynthetic pathways, are marked by distinct histone modifications in TN and TM cells. Furthermore, given the aberrant chromatin modifications found in CD8+ TM cells primed in the absence of CD4+ T cell help, which are impaired in rapid recall ability, identification of the full spectrum of epigenetic differences between TN and TM cells, both functional and dysfunctional, in addition to the transcription factors and enzymes involved in regulating these modifications, should yield a much more detailed understanding of how the TM 'ready-to-respond' state is maintained, and perhaps allow for its therapeutic manipulation.
Transcript profiles
Considering the role that chromatin modifications have in regulating transcription, their characterization should provide insight into studies that have identified the distinct mRNA expression profiles of resting CD8+ TN and TM cells. For instance, in the first comprehensive study of the gene expression profile of CD8+ TM cells generated after acute viral infection, Kaech et al. 37 found higher expression of factors regulating migration, TCR signaling, cell cycle progression and T-cell effector functions in resting TM than in resting TN cells. Specifically, resting TM cells contained ∼two-fold higher transcript levels of the proximal TCR signaling molecules Fyn and Lck. Though Tewari et al. 52 later showed that virus-specific CD8+ TM signaling can be independent of Lck, these results suggest that Fyn may be used by TM cells instead. It was also shown that resting CD8+ TM cells contained higher transcript levels of several cyclins regulating the G1 to S transition, as well as the G2/M cyclin B1. Given that the virus-specific TM cell population contains a very small population of cycling cells at any given time (∼1-3%), it was possible that the expression of S and G2/M cyclins was from these 'contaminating' dividing cells within the total TM cell population. However, in a later study, the same group purified 'resting' TM cells (in G1) and confirmed elevated expression of the G2/M cyclin B1, indicating that TM cells may have a lower threshold for progression into the cell cycle following stimulation 63.
It should be noted that a similar comprehensive transcriptional profiling study was undertaken by Goldrath et al. 27, using CD8+ TM cells generated by LIP. Specifically, naÑ—ve TCR Tg (OT-I; specific for a peptide derived from ovalbumin) cells were adoptively transferred to partially irradiated congenic hosts and TM cells were allowed to develop over 40 or 115 days. At the same time, the authors generated OT-I TM cells by acute pathogenic infection, and identified their unique expression signature, as compared to their TN and TE cell precursors. Notably, the overwhelming majority of these pathogen-driven TM-cell signature genes (95%) were also upregulated in the TM cells generated by LIP. Furthermore, the authors were unable to identify any of the genes induced during LIP-driven TM-cell differentiation that were not also induced in pathogen-driven TM-cell differentiation 27. The major distinction between CD8+ TM cells generated by LIP and pathogen-driven TM cells was the level of gene induction that occurred at early times post-stimulation (< 7 days), which was lower for CD8+ T cells that underwent LIP, especially for genes encoding effector molecules. Nevertheless, multiple comprehensive whole genome analyses of murine T-cell populations have shown that the 'expression signatures' of resting CD8+ TN and TM cells are not identical, independently of whether the TM cells were generated by infection or LIP.
Post-transcriptional regulation of effector molecules
As previously mentioned, it is likely that the functional capacity of CD8+ TM cells is regulated at multiple levels. Although the maintenance of an 'open' chromatin conformation at effector cytokine loci in resting TM cells has been discussed as an explanation for their robust, stimulation-induced cytokine secretion, it is likely that post-transcriptional mechanisms also contribute. Indeed, one example of this regulation of effector molecules in TM cells involves the chemokine RANTES (CCL5). In a series of studies, Marvel and colleagues 64 showed that the level of RANTES mRNA was ∼five-fold higher in resting CD8+ TM cells than in TN cells. This correlated with rapid secretion of RANTES from TM cells, but not from TN cells following stimulation (detectable within 20 min after in vitro stimulation of TM cells). Importantly, TM cell secretion of RANTES was abrogated when translation was inhibited by cycloheximide, but was unaffected when transcription was inhibited by actinomycin D, indicating that stimulation-induced transcriptional upregulation was not responsible for the rapid RANTES secretion. This was in contrast to IFNγ, which was highly upregulated early following stimulation of TM cells in a manner dependent on transcription 64. Whether other chemokines (and/or cytokines) are regulated in a manner similar to RANTES remains to be determined; nonetheless, this example indicates that immediate expression of effector molecules by stimulated TM cells can be dependent on post-transcriptional mechanisms.
Conclusions
In conclusion, though rapid recall ability is a defining characteristic of CD8+ TM cells, we are only beginning to understand how it is acquired, maintained and executed. In the absence of stimulation, when compared to their TN counterparts, there are several distinct properties of TM cells that may contribute to their enhanced responsiveness. These include TM cells' higher level of 'active' (phosphorylated) TCR-proximal signaling components, acquisition of an 'open' chromatin conformation at cytokine and chemokine loci and maintenance of pools of chemokine mRNA that can be rapidly translated following stimulation. In addition, mRNA profiling studies comparing resting TN and TM cells have identified differences in their levels of molecules involved in TCR signaling, migration, proliferation and metabolism. However, the extent to which these transcriptional differences explain the unique properties of resting TM cells (homeostatic proliferation and tissue migration), stimulated TM cells (enhanced proliferation, cytotoxicity and secretion of effector molecules) or both, is not clear. Thus, future studies that identify specific key regulators of TM cells' rapid recall ability are warranted, and should greatly advance our understanding of TM cell biology.
References
Farber DL . Biochemical signaling pathways for memory T cell recall. Semin Immunol 2009; 21:84–91.
Ahmed R, Gray D . Immunological memory and protective immunity: understanding their relation. Science 1996; 272:54–60.
Williams MA, Bevan MJ . Effector and memory CTL differentiation. Annu Rev Immunol 2007; 25:171–192.
Surh CD, Sprent J . Homeostasis of naive and memory T cells. Immunity 2008; 29:848–862.
Harty JT, Badovinac VP . Shaping and reshaping CD8+ T-cell memory. Nat Rev Immunol 2008; 8:107–119.
Harty JT, Tvinnereim AR, White DW . CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol 2000; 18:275–308.
Mescher MF, Curtsinger JM, Agarwal P, et al. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 2006; 211:81–92.
Stemberger C, Huster KM, Koffler M, et al. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity 2007; 27:985–997.
Blattman JN, Antia R, Sourdive DJ, et al. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 2002; 195:657–664.
Busch DH, Pilip IM, Vijh S, Pamer EG . Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998; 8:353–362.
Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998; 8:177–187.
Masopust D . Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location. J Intern Med 2009; 265:125–137.
Vezys V, Yates A, Casey KA, et al. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 2009; 457:196–199.
Schluns KS, Kieper WC, Jameson SC, Lefrancois L . Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1:426–432.
Judge AD, Zhang X, Fujii H, Surh CD, Sprent J . Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J Exp Med 2002; 196:935–946.
Becker TC, Wherry EJ, Boone D, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002; 195:1541–1548.
Goldrath AW, Sivakumar PV, Glaccum M, et al. Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 2002; 195:1515–1522.
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A . Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708–712.
Masopust D, Vezys V, Marzo AL, Lefrancois L . Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413–2417.
Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4:225–234.
Kohlmeier JE, Miller SC, Smith J, et al. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 2008; 29:101–113.
Veiga-Fernandes H, Walter U, Bourgeois C, McLean A, Rocha B . Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol 2000; 1:47–53.
Veiga-Fernandes H, Rocha B . High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. Nat Immunol 2004; 5:31–37.
Haluszczak C, Akue AD, Hamilton SE, et al. The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J Exp Med 2009; 206:435–448.
Hamilton SE, Wolkers MC, Schoenberger SP, Jameson SC . The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat Immunol 2006; 7:475–481.
Barber DL, Wherry EJ, Ahmed R . Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 2003; 171:27–31.
Goldrath AW, Luckey CJ, Park R, Benoist C, Mathis D . The molecular program induced in T cells undergoing homeostatic proliferation. Proc Natl Acad Sci USA 2004; 101:16885–16890.
Jameson SC . Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2002; 2:547–556.
Kieper WC, Jameson SC . Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci USA 1999; 96:13306–13311.
Cho BK, Rao VP, Ge Q, Eisen HN, Chen J . Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med 2000; 192:549–556.
Sun JC, Bevan MJ . Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003; 300:339–342.
Shedlock DJ, Shen H . Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003; 300:337–339.
Goldrath AW, Bevan MJ . Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 1999; 11:183–190.
Woodland DL, Kohlmeier JE . Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol 2009; 9:153–161.
Obar JJ, Khanna KM, Lefrancois L . Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 2008; 28:859–869.
Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM . Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989; 342:559–561.
Kaech SM, Hemby S, Kersh E, Ahmed R . Molecular and functional profiling of memory CD8 T cell differentiation. Cell 2002; 111:837–851.
Northrop JK, Wells AD, Shen H . Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. J Immunol 2008; 181:865–868.
Cerwenka A, Morgan TM, Dutton RW . Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J Immunol 1999; 163:5535–5543.
Hamilton SE, Jameson SC . The nature of the lymphopenic environment dictates protective function of homeostatic-memory CD8+ T cells. Proc Natl Acad Sci USA 2008; 105:18484–18489.
Jones ND, Carvalho-Gaspar M, Luo S, Brook MO, Martin L, Wood KJ . Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol 2006; 176:2316–2323.
Le Saout C, Mennechet S, Taylor N, Hernandez J . Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions. Proc Natl Acad Sci USA 2008; 105:19414–19419.
Pearce EL, Shen H . Generation of CD8 T cell memory is regulated by IL-12. J Immunol 2007; 179:2074–2081.
Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF . Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 2009; 182:2786–2794.
Grayson JM, Harrington LE, Lanier JG, Wherry EJ, Ahmed R . Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo. J Immunol 2002; 169:3760–3770.
Stock AT, Jones CM, Heath WR, Carbone FR . Cutting edge: central memory T cells do not show accelerated proliferation or tissue infiltration in response to localized herpes simplex virus-1 infection. J Immunol 2006; 177:1411–1415.
Sattler A, Wagner U, Rossol M, et al. Cytokine-induced human IFN-gamma-secreting effector-memory Th cells in chronic autoimmune inflammation. Blood 2009; 113:1948–1956.
Bachmann MF, Barner M, Viola A, Kopf M . Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. J Immunol 1999; 29:291–299.
Byers AM, Kemball CC, Moser JM, Lukacher AE . Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J Immunol 2003; 171:17–21.
Slifka MK, Whitton JL . Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat Immunol 2001; 2:711–717.
Kersh EN, Kaech SM, Onami TM, et al. TCR signal transduction in antigen-specific memory CD8 T cells. J Immunol 2003; 170:5455–5463.
Tewari K, Walent J, Svaren J, Zamoyska R, Suresh M . Differential requirement for Lck during primary and memory CD8+ T cell responses. Proc Natl Acad Sci USA 2006; 103:16388–16393.
van Oers NS, Killeen N, Weiss A . Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J Exp Med 1996; 183:1053–1062.
Zarozinski CC, Welsh RM . Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J Exp Med 1997; 185:1629–1639.
Northrop JK, Thomas RM, Wells AD, Shen H . Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells. J Immunol 2006; 177:1062–1069.
Kersh EN, Fitzpatrick DR, Murali-Krishna K, et al. Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J Immunol 2006; 176:4083–4093.
Fitzpatrick DR, Shirley KM, Kelso A . Cutting edge: stable epigenetic inheritance of regional IFN-gamma promoter demethylation in CD44highCD8+ T lymphocytes. J Immunol 1999; 162:5053–5057.
Fitzpatrick DR, Shirley KM, McDonald LE, Bielefeldt-Ohmann H, Kay GF, Kelso A . Distinct methylation of the interferon gamma (IFN-gamma) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytes: regional IFN-gamma promoter demethylation and mRNA expression are heritable in CD44(high)CD8+ T cells. J Exp Med 1998; 188:103–117.
Fann M, Godlove JM, Catalfamo M, et al. Histone acetylation is associated with differential gene expression in the rapid and robust memory CD8(+) T-cell response. Blood 2006; 108:3363–3370.
Shahbazian MD, Grunstein M . Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 2007; 76:75–100.
Araki Y, Wang Z, Zang C, et al. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity 2009; 30:912–925.
Araki Y, Fann M, Wersto R, Weng NP . Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). J Immunol 2008; 180:8102–8108.
Latner DR, Kaech SM, Ahmed R . Enhanced expression of cell cycle regulatory genes in virus-specific memory CD8+ T cells. J Virol 2004; 78:10953–10959.
Walzer T, Marcais A, Saltel F, Bella C, Jurdic P, Marvel J . Cutting edge: immediate RANTES secretion by resting memory CD8 T cells following antigenic stimulation. J Immunol 2003; 170:1615–1619.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is cited by
-
Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response
Scientific Reports (2018)
-
CD301b+ dendritic cells stimulate tissue-resident memory CD8+ T cells to protect against genital HSV-2
Nature Communications (2016)
-
CD45-mediated control of TCR tuning in naïve and memory CD8+ T cells
Nature Communications (2016)
-
Transcriptome Signatures Reveal Rapid Induction of Immune-Responsive Genes in Human Memory CD8+ T Cells
Scientific Reports (2016)
-
Long-term exposure to decabrominated diphenyl ether impairs CD8 T-cell function in adult mice
Cellular & Molecular Immunology (2014)